Role of the different RAR isoforms in controlling the erythrocytic differentiation sequence. Interference with the v-erbA and p135(gag-myb-ets) nuclear oncogenes

Oncogene

Volumn 16, Issue 5, 1998, Pages 563-574

  Gandrillon, Olivier ^a   Samarut, Jacques ^a  

^a UNIVERSITÉ DE LYON   (France)

Author keywords

Erythroleukemia; Nuclear hormone receptors; Viral transformation

Indexed keywords

HORMONE RECEPTOR; ISOPROTEIN; RETINOIC ACID RECEPTOR; RETINOID;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL DIFFERENTIATION; CELL TRANSFORMATION; CONTROLLED STUDY; EMBRYO; ERYTHROCYTE; GENE INDUCTION; NONHUMAN; ONCOGENE C MYB; PRIORITY JOURNAL; RECEPTOR GENE; STEM CELL; VIRUS ONCOGENE;

ANIMALIA; GALLUS GALLUS;

EID: 0032485051     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1201550     Document Type: Article

References (51)

1. Al Moustafa A-E, Gautier R, Saule S, Dieterlen-lièvre F and Cormier F. (1994). Cell Growth Diff., 5, 863-871.
2. Apfel C, Bauer F, Crettaz M, Forni L, Kamber M, Kaufmann F, LeMotte P, Pirson W and Klaus M. (1992). Proc. Natl. Acad. Sci. USA, 89, 7129-7133.
3. Barettino D, Bugge TH, Bartunek P, Vivanco Ruiz MdM, Sonntag-Buck V, Beug H, Zenke M and Stunnenberg HG. (1993). EMBO J., 12, 1343-1354.
4. Beug H, Palmieri S, Freudenstein C, Zentgraf H and Graf T. (1982). Cell, 28, 907-919.
5. Beug H, Von Kirchbach A, Döderlein G, Conscience J-F and Graf T. (1979). Cell, 18, 375-390.
6. Botling J, Öberg F, Törmä H, Tuohimaa P, Bläuer M and Nilsson K. (1996). Cell Growth Differ., 7, 1239-1249.
7. Cassar-Malek I, Marchai S, Rochard P, Wrutniak C, Samarut J and Cabello G. (1997). Oncogene, 14, 1099-1108.
8. Chen HW and Privalsky ML. (1993). Mol. Cell Biol., 13, 5970-5980.
9. Chen J-Y, Clifford J, Zusi C, Starrett J, Tortolani D, Ostrowski J, Reczek PR, Chambon P and Gronemeyer H. (1996). Nature, 382, 819-822.
10. Dey A, Minucci S and Ozato K. (1994). Mol. Cell Biol., 14, 8191-8201.
11. Don RH, Cox PT, Wainwright BJ, Baker K and Mattick JS. (1991). Nucleic Acids Res., 19, 4008.
12. Frampton J, Ramqvist T and Graf T. (1996). Genes Dev., 10, 2720-2731.
13. Fuerstenberg S, Leitner I, Schroeder C, Schwarz H, Vennstrom B and Beug H. (1992). EMBO J., 11, 3355-3365.
14. Gandrillon O, Ferrand N, Michaille J-J, Roze L, Zile MH and Samarut J. (1994). Oncogene, 9, 749-758.
15. Gandrillon O, Jurdic P, Pain B, Desbois C, Madjar J-J, Moscovici MG, Moscovici C and Samarut J. (1989). Cell, 58, 115-121.
16. Gandrillon O, Rascle A and Samarut J. (1995). Int. J. Oncol., 6, 215-231.
17. Geisen C, Denk C, Gremm B, Baust C, Karger A, Bollag W and Schwarz E. (1997). Cancer Res., 57, 1460-1467.
18. Gianni M, Calzi ML, Terao M, Guiso G, Caccia S, Barbui T, Rambaldi A and Garattini E. (1996). Blood, 87, 1520-1531.
19. Graf T and Beug H. (1978). Biochim. Biophys. Acta., 516, 269-299.
20. Hecker KH and Roux KH. (1996). BioTechniques, 20, 478-480.
21. Hermann T, Hoffmann B, Piedrafita FJ, Zhang K-K and Pfahl M. (1993). Oncogene, 8, 55-65.
22. Inaba M, Yawata A, Koshino I, Sato K, Takeuchi M, Takakuwa Y, Manno S, Yuwata Y, Kanzaki A, Sakai J-I, Ban A, Ono K-I and Maede Y. (1996). J. Clin. Invest., 97, 1804-1817.
23. Jing YK, Zhang J, Bleiweiss IJ, Waxman S, Zelent A and Mira-Y-Lopez R. (1996). Faseb J., 10, 1064-1070.
24. Kraut N, Frampton J and Graf T. (1995). Oncogene, 10, 1027-1036.
25. Leprince D, Gegonne A, Coll J, de Taisne C, Schneeberger A, Lagrou C and Stehelin D. (1983). Nature, 306, 395-397.
26. Lewis JB and Mathews MB. (1980). Cell, 21, 303-313.
27. Martin B, Bernardon JM, Cavey MT, Bernard B, Carlavan I, Charpentier B, Pilgrim WR, Shroot B and Reichert U. (1992). Skin Pharmacol., 5, 57-65.
28. Metz T and Graf T. (1991). Cell, 66, 95-105.
29. Mills KJ, Volberg TM, Nervi C, Grippo J, Dawson M and Jetten AM. (1996). Cell Growth Diff., 7, 327-337.
30. Moscovici MG, Jurdic P, Samarut J, Gazzolo L, Mura CV and Moscovici C. (1983). Virology, 129, 65-78.
31. Ness SA, Marknell A and Graf T. (1989). Cell, 59, 1115-1125.
32. Pain B, Melet F, Jurdic P and Samarut J. (1990). New Biol., 2, 284-294.
33. Pain B, Woods CM, Saez J, Flickinger T, Raines M, Kung HJ, Peyrol S, Moscovici C, Moscovici G, Jurdic P, Lazarides E and Samarut J. (1991). Cell, 65, 37-46.
34. Peters LL, Shivdasani RA, Liu S-C, Hanspal M, John KM. Gonzalez JM, Brugnara C, Gwynn B, Mohandas N, Alper SL, Orkin SH and Lux SE. (1996). Cell, 86, 917-927.
35. Radke K, Beug H, Kornfeld S and Graf T. (1982). Cell, 31, 643-653.
36. Rascle A, Ferrand N. Gandrillon O and Samarut J. (1996). Mol. Cell Biol., 16, 6338-6351.
37. Reichert U, Bernardon JM, Charpentier B, Nedoncelle P, Martin B, Bernard BA, Asselineau D, Michel S, Lenoir MC, Delescluse C, Pilgrim WR, Darmon YM and Shroot B. (1993). From molecular biology to therapeutics. Bernard BA and Shroot B. (eds). S Karger: Basel, pp 117-127.
38. Rogers MB. (1996). Cell Growth Differ., 7, 115-122.
39. Roy B, Taneja R and Chambon P. (1995). Mol. Cell Biol., 15, 6481-6487.
40. Rusten LS, Dybedal I, Blomhoff HK, Blomhoff R, Smeland EB and Jacobsen SE. (1996). Blood, 87, 1728-1736.
41. Sande S, Sharif M, Chen H and Privalsky M. (1993). J. Virol., 67, 1067-1074.
42. Schmidt JA, Marshall J, Hayman MJ, Doderlein G and Beug H. (1986). Leuk. Res., 10, 257-272.
43. Schroeder C, Gibson L, Zenke M and Beug H. (1992). Oncogene, 7, 217-227.
44. Schroeder C, Gibson L, Nordstrom C and Beug H. (1993). EMBO J., 12, 951-960.
45. Sharif M and Privalsky ML. (1991). Cell, 66, 885-893.
46. Sharif M and Privalsky ML. (1992). Oncogene, 7, 953-960.
47. Spanjaard RA, Sugawara A, Ikeda M and Chin WW. (1995). J. Biol. Chem., 270, 17429-17436.
48. Woods C, Domenget C, Solari F, Gandrillon O, Lazarides E and Jurdic P. (1995). Endocrinology, 136, 85-95.
49. Xiao JH, Durand B, Chambon P and Voorhees JJ. (1995). J. Biol. Chem., 270, 3001-3011.
50. Yamamoto T, Hihara H, Nishida T, Kawai S and Toyoshima K. (1983). Cell, 34, 225-232.
51. Zenke M, Kahn P, Disela C, Vennstrom B, Leutz A, Keegan K, Hayman MJ, Choi HR, Yew N, Engel JD and Beug H. (1988). Cell, 52, 107-119.